Emed - de
Liver Systems Medicine Against Cancer | LiSyM Cancer
Description: represents a network of twenty German centers and institutions brought together by a 20 Million Euro funding program of the German Government.
striving to develop non-invasive methods for diagnosing and treating NAFLD by combining mathematical modeling and biological research.
Liver Systems Medicine, or LiSyM, was a multidisciplinary research network, in which molecular and cell biologists, clinical researchers, pharmacologists and experts in mathematical modeling examined the liver in its entirety. The Network officially adjourned in June 2021. The successful LiSyM project is followed by the Systems medicine research network for the early detection and prevention of liver cancer “LiSyM- Cancer”: Please read more on the successive network at www.lisym-cancer.org . In LiSyM the ai
Research focuses on the four key, yet overlapping themes of the pillars. Four junior groups also address specific research topics.
Emed - de
Liver Systems Medicine Against Cancer | LiSyM Cancer